Purpose: To develop a framework for identifying and incorporating candidate confounding interaction terms into a regularised cox regression analysis to refine adverse drug reaction signals obtained via longitudinal observational data.
Introduction
Negative side effects of medication, termed adverse drug reactions (ADRs), are a serious burden to healthcare ??. ADRs are estimated as the cause of 6.5% of UK hospitalisations ? and a study investigating US death due to ADRs reported rates between 0.08-0.12 per 100,000 ?. Studies have suggested that the rate of ADRs is increasing annually ?, motivating the improvement of methods for detecting them. Longitudinal observational data have recently been used to complement spontaneous reporting system data for extracting new drug safety information, and are an excellent potential source of information due to the quantity of observational data available and the number of variables recorded. If we could overcome existing issues, mainly confounding, that limit the use of observational data for causal inference then we may be able to aid the discovery of new ADRs.
We are often plagued with confounding when investigating potential causal relationships retrospectively in observational data ? due to the data collection being non-random. When an association between an exposure and outcome is discovered in observational data, it may often be explained by the presence of confounding. A confounding variable is one that leads to distorted effect estimates between an exposure and outcome due to the confounder being associated with both the exposure and outcome. For a variable to be considered a confounder of an exposure and outcome relationship it must be a risk factor of the outcome, it must be associated with the exposure and it can not lie within the causal pathway between the exposure and outcome.
Consider, for example, the situation where we wish to determine the relationship between a drug given to treat hypertension and myocardial infarction. If we naively look at the incidence of myocardial infarction within a year after treatment for patients given the drug and the incidence of myocardial infarction within a randomly chosen year for patients never given the drug, then we are likely to find that myocardial infarction is more common in those given the drug and conclude that the drug is associated with an increased incidence of myocardial infarction. However, our conclusion is likely explained by confounding, as patients given the drug (those with hypertension) are medically different from those who do not have hypertension. It is likely that some of the patients given the drug have a poor diet or are stressed. Poor diet and stress would have contributed to the hypertension but are also risk factors of myocardial infarction. Therefore poor diet and stress would be confounding factors. To correctly determine a relationship between an exposure and outcome it is important to account for confounding variables. Techniques such as risk adjustment, stratification, or equally distributing the confounding variables between the comparison groups are potential ways to reduce confounding ?.
Adjusting for confounders in observational data requires identifying the confounders. Although existing methods aim to address confounding, various studies have shown that existing signal generation methods developed for longitudinal observational data have a high false positive rate ??. This is most likely due to difficulties identifying confounding variables in a data-driven way. Some studies have shown that including a large number of variables, such as drug indications, into drug safety methods can reduce confounding ???, but none of these methods included interactive terms. A medical illness is likely to be a result of multiple variables interacting. For example, cardiovascular disease is common in patients with a genetic predisposition such as familial hypercholesterolemia and based on lifestyle such as diet and exercise. Therefore, it is interactive terms between medical events or drugs that are most likely to correspond to confounding variables.
However, when there are thousands of medical events and drugs, the number of possible interactions is very large. Existing data-driven methods for incorporating interactive terms into regression models include hierarchal lasso, which adds the interactions along with an interaction regularisation term ?, and methods utilising matrix factorisation ?. However, these methods are likely to be highly inefficient when there are thousands of variables to consider (which is often the case for observational data).
Instead, methods such as emergent pattern mining ? that can efficient identify outcome specific associations, even when large numbers of variables are being considered, may be more suitable. A similar idea was used to successfully detect survival associate rules ? based on cox regression and association rule mining. This shows that it is possible to reduce confounding by combining cox regression and association rule mining.
A suitable post-marketing framework that extracts knowledge from longitudinal observational data could be of the form displayed in Figure 1 .
The first stage of the proposed framework is to apply an efficient large-scale signal generation method to find associations between exposures and outcomes. In the first step the method would efficiently search through all the exposure and outcome possibilities to find associated pairs. An example of a suitable signal generation method is the high dimensionality propensity score Figure 1 : Overview of the methodology. Our proposed data-driven signal refinement is applied to ADR signals generated elsewhere to prioritize/filter them before formal evalu6 ation. It will filter some signals that can be explained by confounding and prioritizes the remaining signals ready for evaluation.
(HDPS) ?. The HDPS works by developing a predictive model for taking the drug and then a matched cohort analysis is applied, where controls are selected based on having a high propensity for taking the drug (the predictive model predicts that they would have the drug). The HDPS can limit confounding by accounting for a large number of variables. Unfortunately, it is not without issues ?? and still often signals many false positives ?, this highlights the requirement of additional analysis that can reduce the false positive rate. The second step in the framework is the signal refinement, where complex confounding relationships are discovered and incorporated into a more detailed analysis. The output of the signal refinement is a small set of exposure-outcome pairs that are prioritized for signal evaluation. The final step would be to formally evaluate the remaining signals using a number of different data sources, as establishing a causal relationship requires an accumulation of evidence.
In this paper we focus on the signal refinement stage, as there are no datadriven methods to refine signals, but numerous signal generation and evaluation methods exist. The objective of this research is to develop a datadriven signal refinement methodology that can be applied after ADR signal generation using longitudinal observational data to filter and re-rank the signals by addressing complex confounding. We will test the data-driven methodology by analysing the relationship between numerous drugs and the outcome myocardial infarction (MI). We are exploring three goals:
1. Whether emergent pattern mining can be used to identify candidate interaction confounding covariates in a data-driven way.
2. Whether the inclusion of interaction confounding covariates into a regression analysis can reduce confounding and be used for datadriven ADR signal refinement.
3. Whether lasso and ridge regularisation are suitable techniques to enable the inclusion of a large number of potential interaction covariates.
Materials and Methods

Materials
The longitudinal observational database used in this study is The Health Improvement Network (THIN) database (www.thin-uk.com). 
Analysis Methods
Emergent Pattern Mining
Emergent pattern mining is a type of association rule mining that aims to find differences between databases. Formally, let I = {i1,i2,,in} be the set of n items and t =⊂ X be a transaction containing a set of items. A database is a collection of transactions, denoted by D = {t1,t2,,tm}. The support of an itemset X in database D is the proportion of the database transactions that contain X,
where |D| is the number of transaction in the database. An itemset is frequent if it has a support greater than some user defined minimum support value.
In the drug safety context, I represents the observational databases clinical vocabulary (e.g., International Classification of Diseases and RxNorm), and a patients transaction may correspond to the set of codes that they have recorded in the database during a specified time interval. An itemset is a collection of clinical vocabulary codes (e.g., {drug1, illness350, drug924}), and the support of the itemset is the fraction of the database's patient transactions that contain the itemset.
The idea of emergent pattern mining is to find itemsets that have a higher support in one database than others ?. A simple method for determining the emergent patterns is to find the itemsets that have a sufficiently high support in one of the databases and then calculate the lift,
However, this measure is vulnerable to volatility due to small support values and a bias-adjusted lift may be more suitable,
this measure adds a bias towards 1 when the support is low and is a common approach for dealing with rare events in drug safety [28] .
Cox Regression
Cox regression was chosen as this enables the consideration of the time to event (enabling long term effects to be evaluated) and the inclusion of rightcensored data. Using a method that ignores the time-to-event, such as logistic regression, would likely result in bias, as patients who leave the practice or die from alternative illnesses (right-censored patients) would not be included into the analysis ?. The cox regression model assumes that the hazard at time t given the covariates x and baseline hazard is,
The parameter β is determined by maximising the partial likelihood ?.
Regularised Cox Regression
Regularisation is a technique to prevent models overfitting by adding a constraint to the complexity of the model. This is necessary when there are too many covariates in the model. In terms of cox regression, regularisation techniques add a constraint to the total size of the coefficients in the model.
There are two main forms of regularisation penalty functions, ridge ? and lasso ?. The elastic net regularisation combines both the lasso and ridge penalty functions ?. Lasso regression is a regularised regression that adds a constraint to the total sum of the absolute value of the model coefficients into the optimisation,
This effectively causes some of the coefficients to disappear and is useful when there are a smaller number of medium or large effects. It has problems when there are correlations between covariates, as it will only pick one of the correlated covariates coefficients to be non-zero. Lasso regression has been used successfully with the aim of overcoming confounding in drug safety ?
but no existing approach has included interactive terms.
Ridge regression adds a constraint to the sum of the coefficients squared into the optimisation,
this causes all the coefficients to shrink to zero as lambda tends to infinity.
Ridge regression is useful if there are small effects, which may be the case for
ADRs. Finally, the elastic net linearly combines both ridge and lasso regression penalties,
The regularised cox regression can be used to indicate the relative importance of each variable in determining the time-to-event of MI. If the drug suspected of causing MI is deemed to have a large coefficient by the regularised cox regression then this strengthens our suspicion, especially when alternative risk factors for developing MI are accounted for within the model.
Method
The proposed signal refinement methodology has two steps.
Step 1 involves applying emergent pattern mining to identify sets of medical conditions and medication that are risk factors for developing the outcome (candidate positive confounder interactions) or factors that reduce the likelihood of developing the outcome (candidate negative confounder interactions).
Step 2 involves implementing a cohort study design and a risk adjusted multivariate analysis (e.g. regularised cox regression) with risk adjustment terms accounting for the candidate confounder variables identified in step 1.
Step 1 Candidate interactive confounder identification 2.3.1.1 Select Data
We imitated the data extraction of a case control study design to extract data for the emergent pattern mining. In this step we did not apply a case control design to investigate the effect of exposure, we just extracted the case control 
Create patients transaction baskets
We then create two databases D1 and D2, see Tables 2-3 
   0 otherwise
The candidate positive confounding variables are the 1}. The negative emergent patterns are found in a similar manner but we apply frequent itemset mining to D2 with a minimum support of 0.001 to find all the controls frequent itemsets ID2 and apply frequent itemset mining to D1 with a minimum support of 0.0005 to find all the cases frequent itemsets ID1. We then calculate ) and determine the candidate negative confounding variables as .
For example, if we found that the itemset {Drug110,Illness1020} had a support of 0.05 in D1 (the itemset is found in the medical transactions for every 5 out of 100 patients with MI) and a support of 0.005 in D2 (the itemset is found in the medical transactions for every 5 out of 1000 control patients).
Then {Drug110,Illness1020}) = 1.05/1.005 = 1.045 and would be considered a candidate positive confounding variable.
The minimum support value was a trade off between finding as many itemsets as possible and finding useful itemsets. The minimum support of 0.001 means any identified itemset would be found in a minimum of 1 in 1000 patients with MI. A support value less than 0.001 would likely find irrelevant itemsets, as they would be too rare to be useful. The support was reduced for the comparison database to increase the chance that the itemset is found in both databases frequent itemsets.
Although it is possible to identify itemsets of any size using frequent itemset mining, in this paper we added a constraint to only find itemsets containing 5 items or less. This ensured the method was highly efficient and in general we found that itemsets containing more than 5 items often had small support values, so this constraint is unlikely to affect the results.
Overall we were efficiently able to identify interactions containing up to 5
variables that are associated with developing MI. We found 23808 variables recorded into THIN for patients who had MI recorded, this means we searched through 
6.
, possible interactions to find the most common ones that are associated with developing myocardial infarction. Table 4 displays the results of the emergent pattern mining approach (a list of sets of medical items that occur more for patients with/without the outcome). Finally we select the top k candidate positive confounding variable itemsets (with the greatest ) and the top k negative confounding variable itemsets (with the greatest ). These will be included into the cox regression using indicator variables to mark their presence or absence in each cohort patients medical history prior to their cohort index date. In this study we chose k = 200 as this seemed to give a sufficient number of candidate confounders while still enabling the methodology to be implemented efficiently.
Select emergent patterns
Justification
The motivation for applying a case control study combined with emergent pattern mining is that we can find illnesses/drugs that are more common in the patients who have the exposure compared to those who never develop the exposure. These are the potential risk factors for the exposure, the first criterion necessary for a variable to be a confounder to the exposureoutcome relationship. By excluding patients from the case control data extraction who have the exposures being analysed, we are preventing the discovery of risk factors that are within the causal pathway between exposure and outcome (as this would violate the third criterion necessary for a variable to be a confounder).
2.3.2.
Step 2 Cohort study with risk adjusted multivariate analysis
Select Data
We implement a cohort study design with a 5-year follow up period. Figure   3 .
The covariates used in the cox regression model are the patients age/gender, indicator variables for each of the drug families being investigated
(1 if the patient had a prescription of the drug family recorded prior to or on the index date and 0 otherwise) and indicator variables for each of the 400 candidate confounder itemsets identified in step 1 (1 if the patient has all items in the itemset recorded prior to index date and 0 otherwise). An example of the data used to learn the cox regression model is displayed in Table 5 .
Cox Regression Models
We then implement various regularised cox regression models (using the age/sex and drug family indicator covariates.
Validation
Following standard computer science methodology we split the data into test/train sets. 50% of the data were used to train the cox regression models, as this was ample, and the remaining 50% of the data were used to validate the models. The summary time-dependant area under the receiver operating characteristic curve (AUC) ? was calculated to validate the model fit.
Software
The data were stored and manipulated in MS SQL Server and the analysis was conducted using the open source analysis language R ?. The frequent pattern mining was implemented using the arules package's Apriori algorithm ?, the standard cox regression was implemented using the survival package ?, the regularised cox regression was implemented using the glmnet package ? and the model validation was implemented using the survAUC package.
Results
Emergent pattern mining results
We identified 77,246 eligible patients who had MI recorded and these patients transactions were included into D1. We matched 150,304 patients into D2. The frequent pattern mining was applied to 23,808 items in D1 and One interesting observation of the emergent pattern mining results is that the there were more frequent itemsets discovered for the patients with MI compared to the control group in step 1. One explanation of this is that patients with MI are likely to be similar and share the common risk factors or MI preceding events, so the D1 dataset will be less sparse compared to D2, which consists of a more varied population. Another reason D2 is sparser is that it contained healthier (non-MI) patients, some of which may not have many items recorded. In future work it would be interesting to restrict D2 to patients with certain criteria, such as having a minimum number of items, and investigating how this effects the emergent patterns that are discovered.
Cox regression results
In total we used data for 162,889 patients for the cox regression analysis.
The model concordance for the standard cox regression was 0.82 and none of the covariates violated the proportional hazard assumption. Table 6 presents the ranking of the drug families based on the coefficient values obtained from a cox regression that only used the age/sex and drug family indicator covariates. The non-ADR bisphosphonates (BNF 06060200) was found to have the greatest hazard ratio. Table 7 presents the results of the elastic net regularised cox regression with the 6 drug families, age/sex and 400 candidate interactive confounders as covariates. The two known ADRs were correctly ranked above the non- On the 50% testing data the time dependant AUC for the standard cox regression was 0.816, the lasso regularised cox regression obtained an AUC of 0.825 and the ridge regularised cox regression obtained an AUC of 0.785, indicating strong model fits.
Discussion
This is the first methodology proposed for incorporating candidate interaction confounder covariates into a cox regression for drug safety. The standard cox regression that only considered indication of the various drug families on the day of or prior to index, age and sex ranked bisphosphonates (BNF 06060200), a non-ADR, as the most likely to cause MI. However, incorporating the candidate interaction confounders into the elastic net regression with small values for α reduced the confounding in the analysis -λ* is the maximum lambda that was within 1 standard deviation of the minimal cross-validation error as this was a trade off between maximising regularisation and minimising error.
-Bold entries correspond to the top ranked drug family and correctly ranked the two known ADRs, tricyclic antidepressants (BNF 04030100) and typical antipsychotics (BNF 04020100), above bisphosphonates. As α increased from 0 in the elastic net regression, the framework was unable to reduce the confounding completely and still incorrectly ranked bisphosphonates as the most likely cause of MI. As α increased towards 1 (lasso regression), it was generally observed that the regularised regression did not identify any of the drug families as causes of MI, however, at certain small values of α (e.g., α = 0.1 ,α = 0.05), the lasso effect nicely filters some of the non-MI causing drug families, although bisphosphonates were still ranked above some of the known ADRs. This One possible reason why the elastic net cox regression with α = 0 was able to correctly rank the drug families is that it incorporated more covariates into the model, even those with small effects. The result that the elastic net cox regression with a small α was better than lasso regression, also provides some evidence that the candidate interactive confounder covariates are appropriate, as including them into the cox regression reduced confounding.
The fact that lasso regression shrunk all the drug families coefficients to zero is not unexpected, as lasso regression identifies large/medium effects, but
ADRs that are difficult to distinguish from confounding are likely to have a small effect size. This suggests that the choice of α will depend on the outcome being investigated (e.g., is it common/rare) and the relationship between the drugs and outcome. Rather than relying on the results obtained by picking the optimal lambda for lasso regression, it may be suitable to investigate the results returned for a range of lambdas and identify the order in which the drug family variables are entered into the regularised models as the regularisation decreases. The last n occurring drug family variables (or those with negative coefficients) could then be filtered out. Another possible explanation for elastic net cox regression with α = 0 outperforming lasso is due to unmeasured confounding. If there are many unmeasured confounders, then adding more candidate interaction confounder covariates may increase the chance of identifying a proxy variable for some unmeasured confounding.
Therefore, as elastic net cox regression with a small α includes more covariates it will have an advantage over lasso regression, as it is may overcome some unmeasured confounding.
We purposely chose MI in this study as the outcome of interest due to it having a high background rate, so confounding is a common issue, and also due to missing data problems being common (MI may only be recorded in secondary care and missed from the primary care record). For example, some patients experiencing a MI may not have the event recorded in their primary care records as they may go to hospital. Hospitalisation may also cause the recording date to be incorrect in THIN. By purposely choosing a difficult outcome, we are testing whether the proposed method can overcome both confounding and data recording issues. However, the proposed method does require that the patients have medical histories; otherwise it would not be possible to identify confounders related to outcome progression. This may limit which databases the methodology can be applied to, as longitudinal observational data with short observation periods are less suitable, although even a short period of history may be useful for reducing confounding.
Therefore, it would be useful in future research to determine whether the proposed method can successfully reduce confounding when applied to other outcomes or when implemented for signal refinement using other longitudinal observational data.
Overall the methodology shows promise at refining ADRs by reducing confounding. The results show that combining emergent pattern mining and elastic net cox regression is an effective and efficient data-driven framework for reducing the issue of confounding that is common in longitudinal observational studies. However, further research is required to identify:
• The optimal value for k (the number of candidate confounder covariates)
• The most suitable choice of α for the elastic net (or combination)
• The types of outcomes that are suitable for the method (e.g., common, rare, progressive, chronic, acute)
The proposed methodology has the advantage of being efficient as it is datadriven, it is applicable for analysing both short-term and long-term ADRs and it can remove false ADR signals. However, formal epidemiology study designs will still need to be applied to the unfiltered signals before causality can be established.
Conclusions
In this paper we proposed a novel framework to efficiently enable the inclusion of high-order interactive terms, potentially representing confounders, into a cox regression analysis to refine ADR signals. The framework combines emergent pattern mining, that searches billions of possible interactions to identify terms potentially corresponding to confounders, and regularised cox regression. We investigated the framework by applying it to investigate how likely six different drug families are to cause MI. The drug families were chosen as they are from a reference set developed to evaluate ADR signal detection methods and there have been numerous studies investigating their relationships with MI. A standard cox regression only considering the risk adjustments of age, sex and indicators for the five drug families was shown to be negatively effected by confounding. However, our proposed automated framework for incorporating candidate confounder interaction terms into an elastic net cox regression was shown to be more resilient to confounding and correctly ranked the drug families in order of how likely they are to cause MI. This shows excellent potential for reducing the current high false positive rate issue when using longitudinal observational data for drug safety.
In future work the framework's robustness should be tested by implementing the framework to refine ADR signals for alternative outcomes or by using alternative longitudinal observational data.
